{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T05:29:20Z","timestamp":1671859760857},"reference-count":23,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T00:00:00Z","timestamp":1495843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T00:00:00Z","timestamp":1495843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Serbian Ministry of Education, Science and Technological Development","award":["175007"],"award-info":[{"award-number":["175007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1111\/jcpt.12557","type":"journal-article","created":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T13:56:37Z","timestamp":1495893397000},"page":"585-590","source":"Crossref","is-referenced-by-count":2,"title":["Influence of regular reporting on local <i>Pseudomonas aeruginosa<\/i>\n and <i>Acinetobacter<\/i>\n spp. sensitivity to antibiotics on consumption of antibiotics and resistance patterns"],"prefix":"10.1155","volume":"42","author":[{"given":"Z. M.","family":"Djordjevic","sequence":"first","affiliation":[{"name":"Department to Control Hospital Infections; Clinical Centre Kragujevac; Kragujevac Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Folic","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department; Clinical Centre Kragujevac; Kragujevac Serbia"},{"name":"Faculty of Medical Sciences; University of Kragujevac; Kragujevac Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Jankovic","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department; Clinical Centre Kragujevac; Kragujevac Serbia"},{"name":"Faculty of Medical Sciences; University of Kragujevac; Kragujevac Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2017,5,27]]},"reference":[{"key":"10.1111\/jcpt.12557-BIB0001|jcpt12557-cit-0001","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ajic.2014.05.029","article-title":"International Nosocomial Infection Control Consortium. International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module","volume":"42","author":"Rosenthal","year":"2014","journal-title":"Am J Infect Control"},{"key":"10.1111\/jcpt.12557-BIB0002|jcpt12557-cit-0002","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the Centers for Disease Control and Prevention, 2011-2014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/jcpt.12557-BIB0003|jcpt12557-cit-0003","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13613-016-0199-4","article-title":"What's new in multidrug-resistant pathogens in the ICU?","volume":"6","author":"Zilahi","year":"2016","journal-title":"Ann Intensive Care"},{"key":"10.1111\/jcpt.12557-BIB0004|jcpt12557-cit-0004","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1089\/mdr.2015.0220","article-title":"Multidrug-resistant\u00a0gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging\u00a0treatment\u00a0options","volume":"22","author":"Cerceo","year":"2016","journal-title":"Microb Drug Resist"},{"key":"10.1111\/jcpt.12557-BIB0005|jcpt12557-cit-0005","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ajic.2013.02.018","article-title":"Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: sensitivity to antibiotics and risk factors","volume":"41","author":"Djordjevic","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1111\/jcpt.12557-BIB0006|jcpt12557-cit-0006","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijantimicag.2011.10.004","article-title":"Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options","volume":"39","author":"Kempf","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/jcpt.12557-BIB0007|jcpt12557-cit-0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0885066615619895","article-title":"Antimicrobial resistance in the intensive care unit: a focus on gram-negative bacterial infections","volume":"32","author":"MacVane","year":"2017","journal-title":"J Intensive Care Med"},{"key":"10.1111\/jcpt.12557-BIB0008|jcpt12557-cit-0008","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1017\/ice.2015.283","article-title":"Antibiotic prescribing for urinary tract infections in the emergency department based on local antibiotic resistance patterns: implications for antimicrobial stewardship","volume":"37","author":"Hudepohl","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1111\/jcpt.12557-BIB0009|jcpt12557-cit-0009","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"10.1111\/jcpt.12557-BIB0010|jcpt12557-cit-0010","first-page":"517","volume-title":"Manual of Clinical Microbiology","author":"Kiska","year":"1995"},{"key":"10.1111\/jcpt.12557-BIB0011|jcpt12557-cit-0011","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"CLSI","year":"2014"},{"key":"10.1111\/jcpt.12557-BIB0012|jcpt12557-cit-0012","first-page":"165","article-title":"Guidelines for ATC classification and DDD assignment","volume":"2012","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2013","journal-title":"Oslo"},{"key":"10.1111\/jcpt.12557-BIB0013|jcpt12557-cit-0013","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/s12879-015-1297-x","article-title":"Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data","volume":"15","author":"Oikonomou","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1111\/jcpt.12557-BIB0014|jcpt12557-cit-0014","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ijantimicag.2016.09.025","article-title":"Epidemiology of infections caused by polymyxin-resistant pathogens","volume":"48","author":"Giamarellou","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/jcpt.12557-BIB0015|jcpt12557-cit-0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1179\/1973947814Y.0000000213","article-title":"Trends in the resistance profiles of Acinetobacter baumannii endemic clones in a university hospital of Argentina","volume":"28","author":"Rodr\u00edguez","year":"2016","journal-title":"J Chemother"},{"key":"10.1111\/jcpt.12557-BIB0016|jcpt12557-cit-0016","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/CMR.00001-13","article-title":"Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance","volume":"26","author":"Schechner","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1111\/jcpt.12557-BIB0017|jcpt12557-cit-0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/0974-777X.176142","article-title":"Incidence of multidrug-resistant\u00a0Pseudomonas\u00a0spp in ICU patients with special reference to ESBL, AMPC, MBL and biofilm production","volume":"8","author":"Gupta","year":"2016","journal-title":"J Glob Infect Dis"},{"key":"10.1111\/jcpt.12557-BIB0018|jcpt12557-cit-0018","doi-asserted-by":"crossref","first-page":"561.e7","DOI":"10.1016\/j.cmi.2016.01.026","article-title":"Systematic review of antibiotic consumption in acute care hospitals","volume":"22","author":"Bitterman","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/jcpt.12557-BIB0019|jcpt12557-cit-0019","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/AAC.01348-12","article-title":"Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity?","volume":"57","author":"Pl\u00fcss-Suard","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12557-BIB0020|jcpt12557-cit-0020","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/eri.12.78","article-title":"Colistin: an update on the antibiotic of the 21st century","volume":"10","author":"Biswas","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/jcpt.12557-BIB0021|jcpt12557-cit-0021","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s40265-014-0267-8","article-title":"Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections","volume":"74","author":"Viehman","year":"2014","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1111\/jcpt.12557-BIB0022|jcpt12557-cit-0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"European Society of Clinical Microbiology. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients","volume":"20","author":"Tacconelli","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/jcpt.12557-BIB0023|jcpt12557-cit-0023","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii. Mechanisms and epidemiology","volume":"45","author":"Potron","year":"2015","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12557","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12557\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:02:53Z","timestamp":1671818573000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,27]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12557","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5,27]]}}}